Patent details
300880
Product Name:
Snelwerkende insulin aspart
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300880
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2340033
Status:
Withdrawn
Application number:
300880
Procedural language:
Dutch
First Applicant Residence Country:
Denmark (DK)
Marketing Authorization
Marketing Authorization Number:
EU/1/16/1160
Marketing Authorization Type:
EEA
Marketing Authorization Date:
11/01/2017
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
16/06/2017
First Marketing Authorization date:
11/01/2017
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
22/06/2017
SPC/SPC Extension Expiration Date:
10/01/2032
Lapsed By Expiration Date:
Withdrawal date:
10/10/2017
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
16/06/2017
Name:
Novo Nordisk A/S
Address:
Novo Allé, 2880 BAGSVÆRD, Denmark (DK)
Agent
Name:
ir. M.F.J.M. Ketelaars c.s.
From:
16/06/2017
Address:
NLO
Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
43/17
Publication date:
25/10/2017
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
26/17
Publication date:
28/06/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
24/10/2017
Outgoing Correspondence
Outgoing Letter
1
PDF
/5/5/1/9/6/0800169155/docs/300880_11_outgoingcorrespondence20171025012542912.pdf
11/10/2017
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/5/5/1/9/6/0800169155/docs/300880_9_incomingcorrespondencepaper20171016012914691.pdf
22/06/2017
Outgoing Correspondence
Confirmation receipt request
1
PDF
/5/5/1/9/6/0800169155/docs/300880_1_145720l174.pdf
16/06/2017
SPC Documents
Accompanying letter SPC
2
PDF
/5/5/1/9/6/0800169155/docs/300880_0_supplprotectioncertificate20170622085052102.pdf
16/06/2017
Application Form
First filed application form
2
PDF
/5/5/1/9/6/0800169155/docs/300880_2_applicationform20170622085051913.pdf
16/06/2017
SPC Documents
Marketing Authorization SPC
4
PDF
/5/5/1/9/6/0800169155/docs/300880_3_supplprotectioncertificate20170622085052504.pdf
16/06/2017
SPC Documents
Certificate SPC
1
PDF
/5/5/1/9/6/0800169155/docs/300880_4_supplprotectioncertificate20170622085052195.pdf
16/06/2017
SPC Documents
Summary of the characteristics of the product
17
PDF
/5/5/1/9/6/0800169155/docs/300880_5_supplprotectioncertificate20170622085052612.pdf
16/06/2017
SPC Documents
Marketing Authorization SPC
3
PDF
/5/5/1/9/6/0800169155/docs/300880_6_supplprotectioncertificate20170622085052302.pdf
16/06/2017
SPC Documents
Annex SPC
66
PDF
/5/5/1/9/6/0800169155/docs/300880_7_supplprotectioncertificate20170622085053056.pdf
16/06/2017
SPC Documents
Annex SPC
2
PDF
/5/5/1/9/6/0800169155/docs/300880_8_supplprotectioncertificate20170622085052874.pdf
16/06/2017
SPC Documents
Subsequently filed documents
1
PDF
/5/5/1/9/6/0800169155/docs/300880_10_supplprotectioncertificate20170622012737262.pdf